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Ectopic clustering of Cajal–Retzius 
and subplate cells is an initial 
pathological feature in Pomgnt2-
knockout mice, a model of 
dystroglycanopathy
Naoki Nakagawa1, Hirokazu Yagi2, Koichi Kato2,3, Hiromu Takematsu1 & Shogo Oka1
Aberrant glycosylation of dystroglycan causes congenital muscular dystrophies associated with 
cobblestone lissencephaly, classified as dystroglycanopathy. However, pathological features in the 
onset of brain malformations, including the precise timing and primary cause of the pial basement 
membrane disruption and abnormalities in the migration of pyramidal neurons, remain unexplored. 
Using the Pomgnt2-knockout (KO) mouse as a dystroglycanopathy model, we show that breaches of 
the pial basement membrane appeared at embryonic day 11.5, coinciding with the ectopic clustering 
of Cajal–Retzius cells and subplate neurons and prior to the migration onset of pyramidal neurons. 
Furthermore, in the Pomgnt2-KO cerebral cortex, preplate splitting failure likely occurred due to the 
aggregation of Cajal–Retzius and subplate cells, and migrating pyramidal neurons lost polarity and 
radial orientation. Our findings demonstrate the initial pathological events in dystroglycanopathy 
mice and contribute to our understanding of how dystroglycan dysfunction affects brain 
development and progresses to cobblestone lissencephaly.
Dystroglycanopathy encompasses a group of congenital muscular dystrophies (CMDs), including Walker–
Warburg syndrome, muscle–eye–brain disease, Fukuyama CMD, and several forms of limb-girdle mus-
cular dystrophies1. Dystroglycanopathy shows highly heterogeneous clinical symptoms, ranging from 
CMDs with disorganized brain architecture, mental retardation, and eye abnormalities in the most severe 
cases to adult-onset limb-girdle muscular dystrophy without brain and eye malformations in milder 
cases1. The common molecular feature found in dystroglycanopathy is a deficiency in the glycosylation of 
dystroglycan, which diminishes the ligand-binding activity of this glycoprotein1,2. Dystroglycan is a cell 
surface receptor for several extracellular matrix (ECM) proteins, such as laminin, agrin, and perlecan, 
and plays a central role in the generation of physical and functional linkages between the cell and the 
ECM3,4. Dystroglycan is ubiquitously expressed in a wide variety of organs4, which leads to abnormalities 
in multiple tissues when its function is compromised as in dystroglycanopathy. Although the pathogen-
esis of muscle defects has been extensively studied5–7, brain defects are not fully characterized, especially 
with regard to neurodevelopmental alteration in the initial phase of brain malformation.
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The ligand-binding glycan expressed on dystroglycan is a unique phosphodiester-linked polysaccharide 
structure built on the O-mannose attached to the dystroglycan core protein, which is known as the so-called 
post-phosphoryl modification8. In the glycosylation pathway of dystroglycan, the phosphorylated trisac-
charide [GalNAcβ 1-3GlcNAcβ 1-4(phosphate-6)Man] is first generated on dystroglycan and then the linear 
heteropolymer with ligand-binding ability, which is composed of repeated units of (–3Xylα 1-3GlcAβ 1–), 
is elongated from the trisaccharide presumably via a phosphodiester linkage9,10. However, the linking 
structure connecting the ligand-binding heteropolymer to the phosphorylated trisaccharide is currently 
unknown. Many genes encoding known or putative glycosyltransferases are mutated in patients with dys-
troglycanopathy11. Recent studies have demonstrated that some, but not all, of those gene products actu-
ally possess glycosyltransferase activity, which is directly or indirectly required for the assembly of the 
ligand-binding glycan on dystroglycan9,10,12–18. For example, the attachment of a mannose to the core pro-
tein is catalyzed by an enzyme complex of protein O-mannosyltransferase 1 (POMT1) and POMT216, and 
the terminal heteropolymer is synthesized by like-acetylglucosaminyltransferase (LARGE)9. Moreover, 
we and other researchers recently identified protein O-mannose β -1,4-N-acetylglucosaminyltransferase 
2 (POMGNT2) [also known as glycosyltransferase-like domain-containing 2 (GTDC2) or AGO61] as a 
β -1,4-N-acetylglucosaminyltransferase that synthesizes the GlcNAcβ 1-4Man structure in the phospho-
rylated trisaccharide10,17,18.
Structural brain abnormality in dystroglycanopathy is a type of neuronal migration disorder classified 
as a type II lissencephaly, also known as cobblestone lissencephaly19. In dystroglycanopathy, the pial 
basement membrane is disrupted due to the lack of dystroglycan function, and neurons over-migrate 
beyond the breached basement membrane, resulting in the formation of a neuronal heterotopia and 
perturbation of the six-layered structure of the neocortex19. Disorganized morphologies of radial glial 
fibers are also observed. Accumulating evidence indicates that, in the developing brain, dystroglycan is 
specifically located at the radial glial end feet and plays a critical role in the maintenance of pial basement 
membrane integrity20,21. In contrast, dystroglycan is absent in immature postmitotic neurons during their 
migration phases, whereas it appears in differentiating neurons along with dendritic maturation and 
co-localizes with GABAA receptors at inhibitory synapses21,22. Furthermore, the neuron-specific deple-
tion of dystroglycan in mice causes no overt pathological changes in brain architecture23, indicating that 
the neuronal migration defect may be caused by environmental changes, and not by an alteration of the 
neuron itself. These findings reveal the final outcome of brain defects in dystroglycanopathy and suggest 
that the abnormalities are derived as a secondary defect of neuronal migration due to the dysfunction 
of radial glial cells. However, the initial pathological changes in the neocortical environment and their 
effects on migrating neurons, leading to over-migration, remain unclear.
To clarify the pathogenesis of dystroglycanopathy-associated brain malformation, we analyzed the 
Pomgnt2-knockout (KO) mouse brain as a disease model by focusing on its early developmental stages. 
We observed that Cajal–Retzius cells and subplate neurons formed ectopic clusters in the meningeal 
spaces in the Pomgnt2-KO brain as early as embryonic day 11.5 (E11.5). The ectopic cell cluster forma-
tion coincided with the disruption of the pial basement membrane, but preceded the over-migration of 
excitatory neurons. Moreover, the polarity and radial orientation of migrating excitatory neurons were 
disrupted in the Pomgnt2-KO cortex. Our findings contribute to the understanding of initial patholog-
ical events in the developing brain of the dystroglycanopathy mouse model, which lead to cobblestone 
lissencephaly.
Results
Basement membrane disruption and ectopic cell clusters are obvious at E12.5 in the 
Pomgnt2-KO brain. The Pomgnt2-KO mouse shows a lack of the laminin-binding activity of dystro-
glycan18. Thus, while the loss of POMGNT2 causes perinatal death, Pomgnt2-KO mice could be useful for 
analyzing the development of the cerebral cortex until birth as a dystroglycanopathy model. It remains 
unclear whether the pial basement membrane disruption in dystroglycanopathy is caused by migrat-
ing pyramidal neurons or other pathological events. Therefore, determining whether the pial basement 
membrane disruption is coincident with or already in progress at the radial migration phase of pyramidal 
neurons is important. In the mouse cerebral cortex, the first population of pyramidal neurons (future 
layer VI neurons) is formed at around E12.5 and subsequently migrates toward the pial surface24,25. To 
investigate the neurodevelopmental alterations in the Pomgnt2-KO mouse at E12.5, a coronal section 
of the cerebral cortex was analyzed using immunohistochemistry. Since the phenotype of the Pomgnt2 
heterozygous embryo is grossly normal and indistinguishable from the wild type18, the wild type and 
heterozygous brains were used as controls in this study. In the control brain, the immunoreactivity of 
IIH6, a monoclonal antibody that recognizes the ligand-binding glycan on dystroglycan, was observed 
at the pial surface in association with the basement membrane visualized by laminin immunostaining 
(Fig.  1a,b). This result indicated that dystroglycan localizes at the end feet of radial glial cells, consist-
ent with a previous study21. In contrast, IIH6 immunoreactivity was absent in the Pomgnt2-KO brain 
(Fig. 1a,b), which confirmed that POMGNT2 is required for the glycosylation of dystroglycan. Moreover, 
in the Pomgnt2-KO mouse, the laminin signal at the pial surface was discontinuous and ectopic cell 
clusters were present (Fig. 1a,b).
Laminin is present at both the pial basement membrane and meningeal blood vessel wall in the brain. 
Thus, immunostaining for CD31, a vascular endothelial cell marker, was performed to distinguish these 
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two structures. In the control brain at E12.5, a single layer of the laminin+/CD31– pial basement mem-
brane was visible just beneath the laminin+/CD31+meningeal blood vasculature (Fig. 1c,d). However, in 
the Pomgnt2-KO cortex, co-labeling for laminin and CD31 revealed that most laminin signals at the pial 
surface were located in the blood vessel, and also highlighted that fragmentary remnants of the pial base-
ment membrane were present (Fig. 1c,d). These results demonstrated that the pial basement membrane 
had been severely disrupted before the arrival of migrating pyramidal neurons.
The pial basement membrane is formed at E10.5 but disrupted at E11.5 in the Pomgnt2-KO 
brain. To determine the onset of basement membrane disruption, we analyzed the E10.5 Pomgnt2-KO 
forebrain. In the control forebrain, a single line of pial basement membrane was detected by 
co-immunostaining for laminin and CD31 (Fig. 2a). IIH6-immunoreactivity was also found in associa-
tion with the pial basement membrane in the control cortex, which disappeared in the Pomgnt2-KO cor-
tex (Fig. 2b), demonstrating that dystroglycan was already expressed at E10.5 and that its ligand-binding 
glycans were absent in the Pomgnt2-KO brain. Despite the loss of functional dystroglycan, a continuous 
basement membrane was present in the Pomgnt2-KO brain at E10.5 (Fig.  2a), which suggests that the 
dystroglycan dysfunction does not affect the construction of the pial basement membrane. Next, we 
examined the E11.5 Pomgnt2-KO brain and found breaches of the pial basement membrane at this 
stage (Fig.  2c). Moreover, an ectopic cell cluster was emerging at the gap in the disrupted basement 
membrane (Fig.  2c). Tiny fragments apparently derived from the basement membrane were observed 
over the ectopic cell cluster (Fig.  2d), which implies that the aberrant localization of these cells may 
trigger basement membrane breakdown. Taken together, these results indicate that the ligand-binding 
glycan-dependent function of dystroglycan is not crucial for the assembly of the basement membrane, 
but is essential for its maintenance.
Figure 1. The Pomgnt2-KO cerebral cortex at E12.5 shows severe defects in pial basement membrane 
integrity. (a) Coronal sections of the developing brain from control and Pomgnt2-KO embryos at E12.5  
were immunostained with IIH6 mAb and anti-laminin pAb. (b) Enlarged images of the dorsal cortex in  
(a). Arrowheads indicate ectopically located cells at gaps of discontinuous laminin signals.  
(c) Immunohistochemistry for laminin and CD31 at E12.5. (d) Enlarged images of the pial surface in  
(c). The arrow indicates the laminin+/CD31− pial basement membrane in the control cortex and arrowheads 
show fragmented structures derived from the basement membrane in the Pomgnt2-KO cortex. Scale bars 
represent 200 μ m (a) and 100 μ m (b–d).
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Cajal–Retzius cells and subplate neurons are abnormally distributed and form ectopic clus-
ters. Next, we attempted to identify what kinds of cells populated the ectopic cluster observed in the 
Pomgnt2-KO cortex at E11.5. Three major cell types exist in the E11.5 dorsal cortex: Cajal–Retzius cells, 
subplate neurons, and radial glial cells24,25. Therefore, immunostaining for their marker proteins was 
performed. Calretinin+cells comprising Cajal–Retzius cells and subplate neurons formed a single layer 
just beneath the pia mater in the control cortex, but aggregated at the ectopic clusters in the Pomgnt2-KO 
cortex (Fig.  3a). The ectopic cell clusters were also positive for MAP2 and reelin (Fig.  3b,c), and con-
tained calretinin+/reelin+cells as well as calretinin+/reelin− cells (Fig. 3d), indicating the presence of both 
Cajal–Retzius cells and subplate neurons in the heterotopia. Pax6+radial glial cells were not observed in 
the ectopic cluster (Fig. 3e).
We assessed the alteration of the ectopic cluster along with cortical development. Ectopic clusters 
composed of Cajal–Retzius cells and subplate neurons, which were formed at E11.5, were enlarged in 
size at E12.5 and still observed at E14.5 in Pomgnt2-KO brains (Fig. 4a–e). In the E14.5 control brain, 
substantial amounts of pyramidal neurons had migrated to the upper region of the neocortex and 
formed the cortical plate (CP). Calretinin immunostaining revealed the splitting of the preplate and the 
Figure 2. The pial basement membrane in the Pomgnt2-KO cortex begins to be disrupted at E11.5. 
(a and b) Coronal sections of the forebrain from the control and Pomgnt2-KO embryos at E10.5 were 
immunostained with anti-laminin pAb and anti-CD31 pAb (a) and IIH6 mAb and anti-laminin pAb 
(b). (c) Coronal sections of the cerebral cortex from control and Pomgnt2-KO embryos at E11.5 were 
immunostained for laminin and CD31. Arrowheads indicate the emergence of the ectopic cell cluster at the 
gap in the breach of the pial basement membrane visualized by laminin immunostaining in the Pomgnt2-KO 
brain. (d) Enlarged images of the pial surface of the E11.5 Pomgnt2-KO brain in (c). Arrowheads indicate 
that laminin+/CD31– fragments derived from the pial basement membrane were observed over the ectopic 
cell cluster. The arrow points to the gap in the pial basement membrane. Scale bars represent 50 μ m.
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appearance of the subplate (Fig. 4d), a boundary layer between the CP and intermediate zone composed 
of calretinin+subplate neurons26. In contrast, the subplate was not observed in the Pomgnt2-KO brain 
at E14.5 (Fig. 4d). MAP2 immunostaining also revealed the disruption of the subplate formation in the 
Pomgnt2-KO cortex (Fig. 4f). These data indicate the failure of the preplate splitting in the Pomgnt2-KO 
brain, presumably due to the ectopic aggregation of Cajal–Retzius cells and subplate neurons that would 
normally be split by climbing pyramidal neurons.
The polarized morphology and radial orientation of excitatory neurons are disrupted in the 
Pomgnt2-KO cortex. Since the highly ordered spatial arrangements of Cajal–Retzius cells and sub-
plate neurons are essential for the proper guidance of the radial migration of pyramidal neurons24,25, 
our observation of ectopic cluster formation and preplate splitting failure suggests that the migration 
of pyramidal neurons is disorganized in the Pomgnt2-KO brain. Therefore, we investigated how these 
events in the early developmental stages affected the migration of excitatory neurons, which could lead 
to over-migration and the cobblestone phenotype. The morphology of radially migrating neurons in 
the Pomgnt2-KO cortex was examined by labeling the newborn neurons with green fluorescent protein 
(GFP) using in utero electroporation. A plasmid expressing GFP was electroporated into progenitor cells 
in the ventricular zone of the dorsal cortex at E12.5 to visualize early-born excitatory neurons. We then 
analyzed the positions and morphologies of neurons generated from these progenitor cells at E16.5. In 
the control brain, a substantial number of neurons (44.1 ± 4.4%) reached the upper region of the CP at 
E16.5 (Fig. 5a,c). In contrast, many neurons did not enter the upper CP and remained in the lower CP 
Figure 3. Abnormally located Cajal–Retzius cells and subplate neurons constitute ectopic clusters. 
(a) Coronal sections of the developing brain from control and Pomgnt2-KO embryos at E11.5 were 
immunostained using anti-calretinin pAb. Arrowheads indicate that ectopic cell clusters present in the 
E11.5 Pomgnt2-KO cortex were composed of calretinin+cells. (b–e) Immunohistochemistry of the E11.5 
Pomgnt2-KO cortex for calretinin and MAP2 (b), reelin and laminin (c), reelin and calretinin (d), and Pax6 
and MAP2 (e). Arrowheads in (d) indicate the presence of calretinin+/reelin− cells in the ectopic cluster. 
Note that the MAP2+cell cluster was negative for Pax6 (e). Scale bars represent 100 μ m (a) and 50 μ m (b–e).
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(upper CP, 15.5 ± 3.2%; lower CP, 54.9 ± 4.2%) in the Pomgnt2-KO brain at E16.5 (Fig. 5a,c). Moreover, 
although most of the migrating neurons in the control brain exhibited the bipolar morphology with a 
leading process oriented toward the pial surface, the number of neurons with typical bipolar morphology 
was remarkably diminished in the Pomgnt2-KO brain (control, 89.7 ± 2.6%; Pomgnt2-KO, 21.3 ± 0.5%) 
(Fig.  5a,b,d). Furthermore, many neurons had a misoriented (control, 4.9 ± 0.9%; Pomgnt2-KO, 
22.1 ± 0.6%) or no (control, 5.3 ± 1.7%; Pomgnt2-KO, 56.6 ± 0.8%) leading process (Fig. 5a,b,d), indicat-
ing that the polarity of migrating neurons is lost in the Pomgnt2-KO cortex.
The polarity of excitatory neurons during radial migration was further evaluated by the morphology 
of the Golgi apparatus. In excitatory neurons during the radial migration phase, the Golgi apparatus is 
localized ahead of the nucleus and extends toward the pial surface27,28. GM130 immunostaining revealed 
that a large number of neurons (“radial” in Figs. 5g, 63.9 ± 2.3%) had a typically elongated Golgi appa-
ratus facing in the migratory direction in the control CP (Fig. 5f,g). In contrast, in the Pomgnt2-KO CP, 
the number of Golgi with a radially oriented morphology was markedly reduced (“radial” in Figs.  5g, 
6.8 ± 0.8%), while those with an extended but incorrectly oriented shape (“not radial” in Figs.  5g, 
27.8 ± 1.2%) and globular and compact shapes (“compact” in Figs.  5g, 65.4 ± 0.9%) were increased 
(Fig.  5f,g). These results demonstrated the loss of polarity and radial orientation of migrating excit-
atory neurons in the Pomgnt2-KO brain. In the developing mouse brain, early-born neurons (des-
tined for layers V and VI) and late-born neurons (destined for layers II to IV) differentially utilize the 
radial glia-independent and radial glia-guided modes of radial migration, respectively29,30. The radial 
Figure 4. The calretinin-positive heterotopia is retained along with the development of the Pomgnt2-KO 
brain. (a–c) Coronal sections of the developing brain from control and Pomgnt2-KO embryos at E12.5 
were immunostained for calretinin (a), reelin and laminin (b), and reelin and calretinin (c). Arrowheads 
in (a) and (b) indicate that the ectopic cell clusters observed in the E12.5 Pomgnt2-KO cortex contained 
calretinin+and reelin+cells, respectively. Far right panels in (a) and (b) are the magnified images of the 
pial surface showing that calretinin+(a) and reelin+(b) cells formed a single layer in the control cortex, but 
aggregated in the Pomgnt2-KO cortex. Note that both calretinin+/reelin+and calretinin+/reelin− cells were 
present at the ectopic cluster (c). (d and e) Immunohistochemistry for calretinin (d) and reelin (e) at E14.5. 
Arrowheads in (d) and (e) indicate that calretinin+and reelin+ectopic cell clusters, respectively, were still 
present in the E14.5 Pomgnt2-KO cortex. The calretinin+layer shown by the arrow in (d) is the subplate, 
indicating that the cortical plate (CP) was formed in the control cortex. Far right panels in (e) are the 
magnified images of the pial surface. (f) Immunohistochemistry for MAP2 at E14.5. The arrow indicates the 
subplate formed in the control cortex. Scale bars represent 100 μ m.
www.nature.com/scientificreports/
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glia-guided migration is thought to be disrupted in dystroglycanopathy because radial glial fibers show 
abnormal morphologies due to the lack of dystroglycan function19,21. In this regard, our findings obtained 
from analyses of early-born pyramidal neurons revealed that the radial glia-independent migration was 
also disorganized in dystroglycanopathy.
Figure 5. Excitatory neurons in the Pomgnt2-KO cortex display aberrant migratory behaviors.  
(a) Coronal sections of E16.5 control and Pomgnt2-KO brains following in utero electroporation with the 
pCAGGS-GAP-Venus plasmid (encoding a modified GFP variant) at E12.5. Immunostaining for GFP 
visualizes the distribution and morphology of the migrating neurons. (b) Enlarged images showing a closer 
view of the migrating neurons in (a). In the Pomgnt2-KO cortex, neurons with an incorrectly oriented 
leading process (indicated by arrowheads) or with no leading process (indicated by arrows) were observed. 
Panels are placed with the pial surface to the top. (c–e) Quantification of the distribution of GFP+cells in 
different zones of the CP (c), morphology of GFP+cells (d), and percentage of GFP+cells contacting with the 
pial surface (e). uCP, upper CP; mCP, median CP; lCP, lower CP. The graph shows the mean ± SEM from 
3 embryos for each genotype. Student’s t-test; *P < 0.05, **P < 0.01. (f) Coronal sections of the developing 
brain from control and Pomgnt2-KO embryos at E14.5 were immunostained for GM130 to analyze the 
morphology of the Golgi apparatus. Magnified images of the Golgi apparatus in the CP are shown in the 
insets. (g) Golgi morphology was assigned to three categories (radial, not radial, and compact), and the 
number of Golgi bodies in each category was quantified. The graph shows the mean ± SEM from 4 embryos 
for each genotype. Student’s t-test; ***P < 0.001. Scale bars represent 100 μ m (a), 20 μ m (b), and 50 μ m (f).
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Detachment of leading processes from the pial surface is a likely cause of neuronal migra-
tion defects in the Pomgnt2-KO brain. We investigated the pathological mechanism underlying 
the perturbation of the neuronal migration in the Pomgnt2-KO brain. The decrease in the number of 
neurons that enter the upper CP in the Pomgnt2-KO brain (Fig. 5a,c) is suggestive of a failure of somal 
translocation, the dynamic movement of neurons to reach their final destinations29,30. During somal 
translocation, neurons extend and attach their leading processes to the pial surface and then raise their 
cell bodies by utilizing their leading processes as anchorages29,30. Physical interactions between the neu-
ronal leading process and ECM proteins in the marginal zone (MZ) or the Cajal–Retzius cell membrane 
are important for somal translocation31,32. In the Pomgnt2-KO cerebral cortex, the pial basement mem-
brane is absent and the MZ structure is disorganized because of ectopic cluster formation (Figs  1–3). 
Therefore, neurons may not be able to maintain their leading processes due to the loss of anchorage 
points, and thus fail to raise their cell bodies. Consistent with this hypothesis, in the Pomgnt2-KO cortex, 
neurons in contact with the pial surface were decreased compared to those in the control cortex (con-
trol, 21.0 ± 1.0%; Pomgnt2-KO, 7.2 ± 2.5%) (Fig. 5a,e). Moreover, in the Pomgnt2-KO brain at E12.5 and 
E14.5, nestin-positive fibers appeared to be sparse at the pial surface and terminated without reaching the 
top of the cortical wall, indicating that the basal processes of radial glial cells were detached and retracted 
from the pial surface, while these were in close contact with the pial basement membrane in the control 
brain (Fig.  6a–d). This observation also supports the above possibility because early-born excitatory 
neurons that migrate at around E14.5 have been shown to inherit nestin-positive basal processes from 
parental radial glial cells and use them as anchorages in somal translocation33,34.
Accumulating evidence shows that reelin signaling is essential for neurons to undergo somal trans-
location28,30–32. Therefore, the mislocalization of Cajal–Retzius cells, which are major reelin-producing 
cells, may lead to alteration in the availability of reelin and/or the efficacy of reelin signaling, contribut-
ing to the defects in neuronal migration in the Pomgnt2-KO brain. To test this possibility, we analyzed 
the expression level of reelin and the phosphorylation level of disabled homolog 1 (Dab1), an intra-
cellular adaptor protein that undergoes phosphorylation upon the binding of reelin to its receptors35. 
Immunoblotting analyses using lysates prepared from control and Pomgnt2-KO brains at E16.5 showed 
that the Pomgnt2-KO brain contained similar amounts of reelin as the control brain (Fig. 7a). Moreover, 
no obvious difference was observed in the phosphorylation level or in the total amount of Dab1 between 
the two genotypes (Fig. 7b). These results indicate that reelin signaling is not altered in the Pomgnt2-KO 
brain and is not responsible for the neuronal migration deficiency. Taken together, these findings suggest 
that the detachment of the leading process from the pial surface due to basement membrane disruption 
and ectopic cluster formation is the likely cause of neuronal migration defects in the Pomgnt2-KO brain.
The laminar organization is severely disrupted in the Pomgnt2-KO cortex. The pathological 
alterations observed in the developing brain of Pomgnt2-KO mice, including the preplate splitting failure 
and neuronal migration defects, raised a possibility that the laminar organization of the neocortex is dis-
rupted. Therefore, we examined the cortical lamination in the Pomgnt2-KO brain using brn1 and ctip2 as 
upper- and deep-layer markers, respectively. In contrast to the control cortex where brn1+neurons settled 
superficially to ctip2+neurons, brn1+and ctip2+neurons were intermixed in the Pomgnt2-KO cortex at 
E16.5 and E18.5 (Fig. 8a,b). Moreover, whereas the most superficial region of the cerebral cortex was the 
cell-sparse layer (layer I) in the control brain at E18.5, the region was filled by over-migrated neurons in 
the Pomgnt2-KO brain (Fig. 8b). Both brn1+and ctip2+neurons were present at the heterotopia (Fig. 8b). 
These results indicate that both upper- and deep-layer projection neurons show severe migration defects 
in the Pomgnt2-KO brain, leading to the disruption of the cortical lamination in addition to neuronal 
over-migration.
Discussion
The ligand-binding glycan on dystroglycan serves as a critical mediator for cell–ECM interaction and its 
disruption leads to dystroglycanopathy, a subset of CMDs affecting brain development and skeletal mus-
cles1. The glycosylation-dependent function of dystroglycan is well established in skeletal muscle, where 
it acts as a member of the dystrophin–glycoprotein complex to link the muscle cell cytoskeleton with the 
surrounding ECM components4. The loss of functional dystroglycan increases the susceptibility of the 
sarcolemma to contraction-induced damage, resulting in muscle cell death and myofiber degeneration5–7. 
Dystroglycan is also important in sustaining the integrity of the pial basement membrane in the brain, 
and its dysfunction leads to neuronal over-migration and cobblestone lissencephaly19. The pathological 
features of the initiation phase of the structural brain abnormalities, such as the detailed timing and main 
cause of pial basement membrane disruption and behavioral changes in pyramidal neurons during radial 
migration, remain to be discovered. By analyzing the pathological alterations in the early developmental 
stages of the Pomgnt2-KO mouse brain, we provide deeper insights into how loss of dystroglycan func-
tion gives rise to the brain malformations in dystroglycanopathy.
By focusing on early developmental stages, we found that the pial basement membrane was breached 
at E11.5 in Pomgnt2-KO mice (Fig. 2c and d), coincident with the ectopic clustering of calretinin+cells 
(Fig. 3a). Several mouse models have been established to investigate the brain defects in dystroglycan-
opathy. Because the genetic ablation of dystroglycan (Dag1) in mice leads to early embryonic lethality at 
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E7.536, conditional KO (cKO) mice have been generated to yield the brain-specific deletion of dystrogly-
can and longer survival20,23. Glial fibrillary acidic protein (GFAP)-Cre- or Nestin-Cre-mediated deletion 
of dystroglycan in the central nervous system recapitulated the structural brain defects found in patients 
with dystroglycanopathy, such as basement membrane disruption, neuronal migration defects, and neu-
ronal heterotopia formation20,23. Moreover, using these model mice, it has been shown that dystroglycan in 
radial glial cells, but not in neurons, is important in maintaining the brain architecture23, and that proper 
axonal projections to appropriate targets are observed despite the mispositioning of pyramidal neurons21. 
These model mice are useful for clarifying and characterizing the final outcome of brain abnormalities 
in dystroglycanopathy, but the analysis of disease onset is limited due to the residual effects of dystrogly-
can produced before Cre-mediated inactivation. Indeed, dystroglycan cKO (Nestin-Cre/Dag1lox/lox) mice 
exhibit a delayed onset of basement membrane disruption at E15.521 compared to Pomgnt2-KO mice, in 
Figure 6. Nestin-positive fibers are detached from the pial surface in the Pomgnt2-KO cortex. (a–d) 
Coronal sections of the developing brain from control and Pomgnt2-KO embryos at E12.5 (a and b) and 
E14.5 (c and d) were immunostained for nestin and laminin. Magnified images of the pial surface in  
(a) and (c) are shown in (b) and (d), respectively. Arrowheads indicate the incorrectly terminated fibers that 
did not penetrate the entire thickness of the cerebral cortex, which were typically observed at aberrant cell 
aggregates. Scale bars represent 100 μ m.
www.nature.com/scientificreports/
1 0Scientific RepoRts | 5:11163 | DOi: 10.1038/srep11163
which dystroglycan function is disrupted throughout development (Fig. 2c,d). Mice lacking O-mannose 
β-1,2-N-acetylglucosaminyltransferase 1 (Pomgnt1), one of the genes involved in dystroglycanopathy, also 
develop cobblestone lissencephaly-like cortical dysplasia37. As in Pomgnt2-KO mice, Pomgnt1-KO mice 
show defects in the glycosylation of dystroglycan throughout development, but these two mice differ in 
their disease onsets. The pial basement membrane is intact at E11.5 and rapidly disrupted by E13.5 in 
Pomgnt1-KO mice37. Of note, the precise role of POMGNT1 in production of the ligand-binding glycan 
on dystroglycan has not yet been clarified. POMGNT1 can affect the glycan composition of dystroglycan 
in an independent way from post-phosphoryl modification13, which may account for the apparent phe-
notypic divergence between Pomgnt2- and Pomgnt1-KO mice. Therefore, the Pomgnt2-KO mouse could 
be a useful model to investigate the early phase of dystroglycanopathy-associated brain malformation. 
For the future expansion of studies on dystroglycanopathy, utilizing the appropriate mouse model is 
important in accordance with the period when the pathological changes of interest occur.
In the Pomgnt2-KO cerebral cortex, Cajal–Retzius cells and subplate neurons ectopically aggregated at 
meningeal spaces and formed heterotopia (Figs 3 and 4). Given that the emergence of calretinin+ectopic 
clusters corresponded to the timing and region of the basement membrane breach and that fragmented 
laminin signals were observed over the cluster (Figs 2 and 3), the aberrant aggregation of Cajal–Retzius 
cells and subplate neurons may be contributing factors in the basement membrane disruption. In normal 
corticogenesis, Cajal–Retzius cells and subplate neurons are both aligned in two distinct layers beneath 
the pial surface and form the preplate24–26. Several lines of evidence show that the migration and local-
ization of Cajal–Retzius cells in the developing brain are regulated by chemokine signaling, especially 
CXCL12 (also known as stromal cell-derived factor-1, SDF-1) and its receptor CXCR438,39. CXCL12, 
produced by meningeal cells, enhances the tangential migration of CXCR4-expressing Cajal–Retzius cells 
and restricts their trajectories to the superficial-most side of the MZ38,39. Notably, chemokines, includ-
ing CXCL12, are highly basic proteins and bind to negatively charged glycans, such as glycosaminogly-
cans40,41, and this chemokine–carbohydrate interaction is known to regulate the local distribution of 
chemokines41,42. Therefore, considering that the ligand-binding heteropolymer on dystroglycan seems 
to bear negative charges because it contains GlcA, the aberrant glycosylation of dystroglycan located at 
radial glial end feet facing the meninges may alter the local concentration of CXCL12 around the MZ, 
resulting in perturbation of the positioning of Cajal–Retzius cells. Although this idea is just a hypothesis 
and interactions between chemokines and dystroglycan have not yet been examined, it may be a distinct 
aspect of dystroglycan function.
While the final outcome of the neuronal migration defects in dystroglycanopathy has been iden-
tified as the over-migration, behavioral changes in the migrating neurons during their journey to the 
pial surface are not well characterized. In the Pomgnt2-KO cerebral cortex, we revealed that migrating 
pyramidal neurons display abnormal morphologies in the leading process and Golgi apparatus, indicat-
ing a disappearance of polarity and migration directionality (Fig. 5). We also observed preplate splitting 
failure in the Pomgnt2-KO brain (Fig. 4). Preplate splitting is a characteristic process in early neocortical 
development, whereby the two layers of Cajal–Retzius cells and subplate neurons are divided by pyrami-
dal neurons migrating toward the pial surface, resulting in the generation of the CP24. Failure of preplate 
splitting is a prominent feature of mice with deficiencies in the reelin signaling pathway, such as the 
reeler mutant, Dab1 mutant, and the double mutant of reelin receptors apolipoprotein E receptor 2 and 
Figure 7. Reelin signaling is unchanged in the Pomgnt2-KO brain. (a and b) Brain lysates prepared 
from control and Pomgnt2-KO embryos at E16.5 were analyzed by immunoblotting. Actin was used as a 
loading control. Total amounts of reelin and Dab1 were assessed using anti-reelin mAb (a) and anti-Dab1 
pAb (b, input), respectively. The phosphorylation level of Dab1 was evaluated by immunoblotting with anti-
phosphotyrosine (pTyr) mAb using samples immunoprecipitated with the anti-Dab1 antibody (b, IP: Dab1). 
IP, immunoprecipitation. The full-length blots with anti-reelin, anti-Dab1, and anti-pTyr antibodies are 
presented in Supplementary Figs. S1a and S1b.
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very low-density lipoprotein receptor43–45. Neurons lacking reelin signaling cannot maintain their leading 
processes due to the dysregulation of adhesion molecules, resulting in a defect in somal translocation 
that leads to preplate splitting failure28,31,32. In addition, neuronal polarity was also affected in reeler 
mice27,46. These reeler neuronal phenotypes apparently resemble the behaviors of migrating neurons in 
the Pomgnt2-KO brain (Fig. 5). Thus, we examined reelin signaling in the Pomgnt2-KO brain, but found 
that it was unchanged (Fig.  7). Previous studies showed that the reelin signaling triggered the recruit-
ment of N-cadherin to the neuronal cell surface and the activation of integrin α 5β 1, enabling neurons 
to attach to scaffolds present in the MZ, such as the Cajal–Retzius cell membrane and fibronectin28,31,32. 
Since reelin signaling is intact in the Pomgnt2-KO brain, we speculate that neurons may be unable to 
maintain their leading processes and rise due to the loss of those anchorage substances caused by the dis-
appearance of the basement membrane and/or ectopic cluster formation. Therefore, this study highlights 
the essential role of glycans on dystroglycan in the maintenance of the neocortical environment required 
for the neuronal positioning. Although POMGNT2 seems to be expressed by both radial glial cells and 
migrating neurons because its mRNA is found throughout the developing mouse brain including the 
ventricular zone and CP47, dystroglycan shows a restricted expression in radial glial cells and is not likely 
to function in neurons during the development of the cortical lamination21,23. These observations indicate 
that, together with dystroglycan, POMGNT2 functions in radial glial cells but not in migrating neurons 
during the brain development21,23. Our findings indicate the importance of the appropriate environment 
in the cerebral cortex in addition to the intrinsic machinery in the neuron for proper migration and layer 
formation of pyramidal neurons.
Methods
Antibodies. The following primary antibodies were used in this study: IIH6 monoclonal antibody 
(mAb) (Millipore, Billerica, MA), anti-laminin polyclonal antibody (pAb) (Sigma-Aldrich, St. Louis, 
MO), anti-CD31 mAb (BD Biosciences, San Jose, CA), anti-calretinin pAb (Millipore), anti-MAP2 mAb 
(Millipore), anti-reelin mAb (Chemicon, Temecula, CA), anti-reelin pAb (R&D Systems, Minneapolis, 
MN), anti-Pax6 pAb (Covance, Emeryville, CA), anti-GFP pAb (Clontech, Palo Alto, CA), anti-GM130 
mAb (BD Biosciences), anti-Nestin mAb (Cell Signaling Technology, Danvers, MA), anti-actin pAb 
(Millipore), anti-Dab1 pAb (Millipore), anti-phosphotyrosine mAb (clone 4G10: Millipore), anti-brn1 
pAb (Santa Cruz Biotechnology, Dallas, TX), and anti-ctip2 mAb (abcam, Cambridge, UK). As sec-
ondary antibodies, the horseradish peroxidase (HRP)-conjugated anti-mouse IgG and anti-rabbit IgG 
(Invitrogen, Carlsbad, CA) were used for immunoblotting, and Alexa Fluor 488- or 546-conjugated 
anti-mouse IgG, anti-rabbit IgG, and anti-rat IgG (Invitrogen) were used for immunofluorescence.
Figure 8. The Pomgnt2-KO cortex shows an abnormal cortical lamination. (a and b) Coronal 
sections of the developing brain from control and Pomgnt2-KO embryos at E16.5 (a) and E18.5 (b) 
were immunostained for brn1 (layers II-IV) and ctip2 (layer V). The bracket in (b) shows that the most 
superficial region of the cortex is occupied by over-migrated neurons in the Pomgnt2-KO brain, where the 
cell-sparse layer I is formed in the control brain. Scale bars represent 100 μ m.
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Mice. The Pomgnt2-KO mouse was previously established18. All animal experiments were conducted 
according to the Fundamental Guidelines for Proper Conduct of Animal Experiments and Related 
Activities in Academic Research Institutions under the jurisdiction of the Ministry of Education, Culture, 
Sports, Science and Technology of Japan and approved by the Committees for Animal Experiments of 
Kyoto University and Nagoya City University. For timed pregnancy mating, noon on the plug date was 
considered as E0.5.
Immunohistochemistry. Embryos or dissected brains were fixed in phosphate-buffered saline (PBS) 
containing 4% paraformaldehyde, cryoprotected in PBS containing 30% sucrose, and embedded in OCT 
compound (Sakura Finetek, Tokyo, Japan). Coronal sections (12 or 20 μ m thick) were prepared from 
the embedded tissues and incubated for 20 min at room temperature in blocking solution (PBS con-
taining 3% bovine serum albumin and 0.1% Triton X-100). Sections were then incubated with primary 
antibodies overnight at 4 °C followed by incubation with secondary antibodies at room temperature for 
2 h. 4’,6-Diamidino-2-phenylindole (DAPI) was used for nuclear counterstaining. For the morphological 
analysis of the Golgi apparatus, Golgi morphologies visualized by GM130 staining were split into three 
categories: radial, not radial, and compact. Among the thin and extended Golgi bodies, those with a 
vertical orientation (angle range ± 30° from the vertical line to the pial surface) were assigned into the 
“radial” category, and those with other orientations were considered “not radial”. Golgi bodies with glob-
ular and compact shapes were assigned to the “compact” category.
Expression plasmid. An expression vector for Venus (a GFP variant with the enhanced fluorescence) 
attached to a membrane-targeted palmitoylation signal of GAP-43 (pCAGGS-GAP-Venus)48 was kindly 
provided by Drs. Y. Yoshihara and A. Miyawaki (RIKEN Brain Science Institute, Wako, Saitama, Japan).
In utero electroporation. In utero electroporation was conducted according to an established proce-
dure49. Briefly, timed-pregnant mice were anesthetized and the uterine horns were exposed. The plasmid 
solution containing 1 μ g/μ l of cDNA and 0.01% Fast Green solution was injected into the lateral ventricle 
of the embryonic brain at E12.5 using a pulled glass capillary. The head was clasped by a pair electrode 
(NEPA Gene, Chiba, Japan) and electric pulses (30 V for 50 ms, five times in 950-ms intervals) were 
delivered using an electroporator (NEPA Gene).
Preparation of mouse brain lysates. Whole brains of E16.5 control and Pomgnt2-KO mice were 
homogenized using a polytron homogenizer in nine volumes of homogenization buffer [20 mM Tris–
HCl (pH 7.4), containing 150 mM NaCl, 1 mM ethylenediaminetetraacetic acid (EDTA), 1 mM sodium 
orthovanadate, and a protease inhibitor cocktail (Nacalai Tesque, Kyoto, Japan)]. The homogenate was 
centrifuged at 1,000 × g for 10 min at 4 °C to remove nuclei and large debris. Then, Triton X-100 (1% 
final concentration) was added to the supernatant, followed by incubation for 30 min at 4 °C and cen-
trifugation at 105,000 × g for 60 min at 4 °C. The resulting supernatant was used as the brain lysate for 
biochemical experiments.
Immunoprecipitation and immunoblotting. For immunoprecipitation, the brain lysate was incu-
bated with the primary antibody and protein G-conjugated Sepharose (GE Healthcare, Little Chalfont, 
Buckinghamshire, UK) for 2 h at 4 °C. The beads were recovered by centrifugation (400 × g for 2 min) 
and washed three times with Tris-buffered saline containing 0.1% Triton X-100. The beads were boiled 
in Laemmli sample buffer, and eluted proteins were subjected to sodium dodecyl sulfate–polyacrylamide 
gel electrophoresis (SDS-PAGE). For immunoblotting, solubilized proteins were separated by SDS-PAGE 
on a 10% polyacrylamide gel and transferred onto nitrocellulose membranes. After blocking with 5% 
nonfat dry milk in PBS containing 0.05% Tween 20, membranes were incubated with primary antibod-
ies, followed by the incubation with HRP-conjugated secondary antibodies. Protein bands were detected 
using the Super Signal West Pico chemiluminescence reagent (Thermo Fisher Scientific, Waltham, MA) 
and a LAS-3000 Luminoimage Analyzer (Fujifilm, Tokyo, Japan).
Statistics. Statistical significance was determined by a two-tailed Student’s t-test. P-values of < 0.05 
were considered statistically significant.
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